ATE99315T1 - Platin(ii)-komplexe, verfahren zu ihrer herstellung und anwendung als antitumormittel. - Google Patents

Platin(ii)-komplexe, verfahren zu ihrer herstellung und anwendung als antitumormittel.

Info

Publication number
ATE99315T1
ATE99315T1 AT89105369T AT89105369T ATE99315T1 AT E99315 T1 ATE99315 T1 AT E99315T1 AT 89105369 T AT89105369 T AT 89105369T AT 89105369 T AT89105369 T AT 89105369T AT E99315 T1 ATE99315 T1 AT E99315T1
Authority
AT
Austria
Prior art keywords
antitumors
complexes
platinum
production
application
Prior art date
Application number
AT89105369T
Other languages
English (en)
Inventor
Silvano Spinelli
Ernesto Menta
Alessandro Pasini
Franco Zunino
Sergio Tognella
Original Assignee
Boehringer Mannheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Italia filed Critical Boehringer Mannheim Italia
Application granted granted Critical
Publication of ATE99315T1 publication Critical patent/ATE99315T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89105369T 1988-04-01 1989-03-25 Platin(ii)-komplexe, verfahren zu ihrer herstellung und anwendung als antitumormittel. ATE99315T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8820074A IT1216687B (it) 1988-04-01 1988-04-01 Complessi di platino (ii), loro preparazione e impiego come antitumorali.
EP89105369A EP0341409B1 (de) 1988-04-01 1989-03-25 Platin(II)-Komplexe, Verfahren zu ihrer Herstellung und Anwendung als Antitumormittel

Publications (1)

Publication Number Publication Date
ATE99315T1 true ATE99315T1 (de) 1994-01-15

Family

ID=11163596

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89105369T ATE99315T1 (de) 1988-04-01 1989-03-25 Platin(ii)-komplexe, verfahren zu ihrer herstellung und anwendung als antitumormittel.

Country Status (12)

Country Link
US (1) US5104895A (de)
EP (2) EP0415939A1 (de)
JP (1) JPH03503529A (de)
AT (1) ATE99315T1 (de)
AU (1) AU633817B2 (de)
DE (1) DE68911745T2 (de)
DK (1) DK235690A (de)
ES (1) ES2061756T3 (de)
HU (1) HU206220B (de)
IT (1) IT1216687B (de)
WO (1) WO1989009218A1 (de)
ZA (1) ZA892398B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1238693B (it) * 1990-02-16 1993-09-01 Montedipe Srl Mescole a base di polimeri vinilaromatici ad elevate caratteristiche meccaniche
EP0550385A1 (de) * 1991-12-19 1993-07-07 Ciba-Geigy Ag Peroral zu verabreichende pharmazeutische Zusammensetzungen, die Methandiphosphonsäure-Derivate und 18-Krone-6 Ether enthalten
US6900012B1 (en) 1997-06-03 2005-05-31 The University Of Chicago Plant artificial chromosome compositions and methods
US7166733B2 (en) * 2000-01-04 2007-01-23 Access Pharmaceuticals, Inc. O,O'-Amidomalonate and N,O-Amidomalonate platinum complexes
US7138520B2 (en) * 2003-01-13 2006-11-21 Massachusetts Institute Of Technology Coordination complexes having tethered therapeutic agents and/or targeting moieties, and methods of making and using the same
JP2007505837A (ja) * 2003-09-15 2007-03-15 オードウェイ リサーチ インスティテュート 甲状腺ホルモンアナログおよび新脈管形成における使用の方法
US9198887B2 (en) 2003-09-15 2015-12-01 Nanopharmaceuticals Llc Thyroid hormone analogs and methods of use
US8071134B2 (en) * 2003-09-15 2011-12-06 Ordway Research Institute, Inc. Thyroid hormone analogs and methods of use
US8668926B1 (en) 2003-09-15 2014-03-11 Shaker A. Mousa Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
HRP20140361T1 (hr) * 2003-12-16 2014-05-23 Nektar Therapeutics Monodisperzne smjese pegiliranog naloksola
ES2568516T3 (es) * 2005-04-19 2016-04-29 Merck Patent Gmbh Antioxidantes
US20090022806A1 (en) * 2006-12-22 2009-01-22 Mousa Shaker A Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists and formulations and uses thereof
US9498536B2 (en) 2005-09-15 2016-11-22 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
US10130686B2 (en) 2005-09-15 2018-11-20 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders
US9220788B2 (en) * 2009-06-17 2015-12-29 Nanopharmaceuticals Llc Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
WO2007035612A2 (en) 2005-09-16 2007-03-29 Ordway Research Institute, Inc. Polyphenol conjugates as rgd-binding compounds and methods of use
JP2010513526A (ja) * 2006-12-22 2010-04-30 シーエルエフ メディカル テクノロジー アクセラレーション プログラム インコーポレイテッド 甲状腺ホルモン類縁体、拮抗剤および製剤のためのナノ粒子及び重合体製剤ならびにその使用
US20110105445A1 (en) * 2008-03-12 2011-05-05 University Of Maryland, Baltimore Androgen receptor inactivation contributes to antitumor efficacy of cyp17 inhibitors in prostate cancer
US20100048524A1 (en) 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
WO2010075332A1 (en) * 2008-12-23 2010-07-01 Charitable Leadership Foundation Small molecule ligands of the integrin rgd recognition site and methods of use
WO2010091306A1 (en) 2009-02-05 2010-08-12 Tokai Pharmaceuticals Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens
US9180107B2 (en) * 2009-03-31 2015-11-10 Nanopharmaceuticals Llc Combination treatment of cancer with cetuximab and tetrac
US8802240B2 (en) 2011-01-06 2014-08-12 Nanopharmaceuticals Llc Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells
EP2968370A4 (de) 2013-03-14 2016-09-21 Univ Maryland Mittel zur androgenrezeptor-abwärtsregelung und verwendungen davon
EP3033088A4 (de) 2013-08-12 2017-03-08 Tokai Pharmaceuticals, Inc. Biomarker zur behandlung neoplastischer störungen mit androgen-anzielenden therapien
WO2015074050A1 (en) 2013-11-18 2015-05-21 Nanopharmaceuticals Llc Methods for screening patients for resistance to angioinhibition, treatment and prophylaxis thereof
US10201616B2 (en) 2016-06-07 2019-02-12 Nanopharmaceuticals, Llc Non-cleavable polymer conjugated with αVβ3 integrin thyroid antagonists
US11351137B2 (en) 2018-04-11 2022-06-07 Nanopharmaceuticals Llc Composition and method for dual targeting in treatment of neuroendocrine tumors
US10328043B1 (en) 2018-04-11 2019-06-25 Nanopharmaceuticals, Llc. Composition and method for dual targeting in treatment of neuroendocrine tumors
US10961204B1 (en) 2020-04-29 2021-03-30 Nanopharmaceuticals Llc Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors
US11723888B2 (en) 2021-12-09 2023-08-15 Nanopharmaceuticals Llc Polymer conjugated thyrointegrin antagonists

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL67789A (en) * 1983-01-31 1986-09-30 Yissum Res Dev Co Amino-substituted malonato platinum(ii)complexes and method for their preparation
US4565884A (en) * 1983-05-10 1986-01-21 Andrulis Research Corporation Bis-platinum complexes as antitumor agents
JPS61500909A (ja) * 1984-01-23 1986-05-08 インスチツ−ト　オブスチエイ　イ　ネオルガニチエスコイ　ヒミイ　イメ−ニ　エヌ．エス．クルナコワ　アカデミ−　ナウク　エスエスエスエル 混合カルボキシラト白金（２）錯体類およびその製法
GB8416048D0 (en) * 1984-06-22 1984-07-25 Johnson Matthey Plc Anti-tumour compounds of platinum
EP0169645A1 (de) * 1984-06-27 1986-01-29 Johnson Matthey Public Limited Company Platin-Koordinationsverbindungen
DE3582961D1 (de) * 1984-06-27 1991-07-04 Johnson Matthey Plc Platinkoordinationsverbindungen.
DE3432320A1 (de) * 1984-09-03 1986-03-13 Behringwerke Ag, 3550 Marburg Cis-platin-komplexe mit einem pentaerythritderivat als liganden, verfahren zu ihrer herstellung und diese verbindungen enthaltendes pharmazeutisches mittel
US4665210A (en) * 1984-12-17 1987-05-12 American Cyanamid Company Platinum complexes of aliphatic tricarboxylic acids
US4737589A (en) * 1985-08-27 1988-04-12 Nippon Kayaku Kabushiki Kaisha Platinum Complexes
JPS62207283A (ja) * 1986-03-07 1987-09-11 Yoshinori Kitani 新規な白金錯体
DE3630497A1 (de) * 1986-09-08 1988-03-10 Behringwerke Ag Cis-platin-komplexe, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
JPS63203692A (ja) * 1987-02-19 1988-08-23 Nippon Kayaku Co Ltd 新規白金錯体
US4882447A (en) * 1987-02-20 1989-11-21 Tanabe Seiyaku Co., Ltd. Novel organic platinum complex and process for the preparation thereof
IL85595A0 (en) * 1987-03-06 1988-08-31 Tanabe Seiyaku Co Organic platinum complex and its preparation
US4904809A (en) * 1987-09-25 1990-02-27 Ss Pharmaceutical Co., Ltd. Platinum complex
EP0376076A1 (de) * 1988-12-27 1990-07-04 Ss Pharmaceutical Co., Ltd. Platinkomplexe
JP2740919B2 (ja) * 1989-03-30 1998-04-15 塩野義製薬株式会社 白金錯体およびこれらを有効成分として含有する抗腫瘍剤
US4994591A (en) * 1989-06-02 1991-02-19 The Research Foundation Of State University Of Ny Platinum complexes derived from b-silyamines

Also Published As

Publication number Publication date
AU633817B2 (en) 1993-02-11
AU3292789A (en) 1989-10-16
DE68911745D1 (de) 1994-02-10
EP0341409A1 (de) 1989-11-15
IT8820074A0 (it) 1988-04-01
HUT55401A (en) 1991-05-28
ES2061756T3 (es) 1994-12-16
DK235690D0 (da) 1990-09-28
US5104895A (en) 1992-04-14
IT1216687B (it) 1990-03-08
HU892555D0 (en) 1991-03-28
EP0415939A1 (de) 1991-03-13
DK235690A (da) 1990-09-28
DE68911745T2 (de) 1994-05-19
HU206220B (en) 1992-09-28
ZA892398B (en) 1989-11-29
EP0341409B1 (de) 1993-12-29
JPH03503529A (ja) 1991-08-08
WO1989009218A1 (en) 1989-10-05

Similar Documents

Publication Publication Date Title
DE68911745D1 (de) Platin(II)-Komplexe, Verfahren zu ihrer Herstellung und Anwendung als Antitumormittel.
MD420C2 (ro) Derivaţi ai acidului acrilic
ATE65500T1 (de) Arylthioalkylphenylcarbonsaeuren, diese enthaltende zusammensetzungen und deren verwendung.
ATE35810T1 (de) Verfahren zur herstellung von optisch aktiven alpha-arylalkansaeuren und ihre zwischenprodukte.
ATE59646T1 (de) 4-brommethyl-5-methyl-1,3-dioxolen-2 -on und verfahren zu seiner herstellung.
ATE55116T1 (de) Neue sulfobetaine von ammoniocarbonsaeureamiden und verfahren zu ihrer herstellung.
ATE67199T1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
DE3870096D1 (de) 2,4,6-triaminopyrimidin n-3-oxid-harnstoff-derivate, deren herstellung und deren kosmetische und dermopharmazeutische verwendung.
ATE73445T1 (de) 1,2,5,6-tetrahydropyridinoxim-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel und diese enthaltende zusammensetzungen.
GR3030234T3 (en) 4-Phenylcarbamoyl-3-isoxazolecarboxylic acid derivatives with antiinflammatory activity
ATE62233T1 (de) Imidazolderivate, verfahren zu deren herstellung und deren anwendung als fungizide.
AR248276A1 (es) Derivados de imidazolidina, procedimiento para producirlos y pesticidas que los contienen
TW328083B (en) New derivatives of β-methoxy acrylic acid, their preparation process and their use as pesticides
ATE82747T1 (de) Verfahren zur herstellung von hydroxyalkylierungsmitteln, die erhaltenen mittel und deren verwendung.
ATE111888T1 (de) Verfahren zur herstellung von optisch aktiver aminosäure.
NO934058L (de)
DE3673129D1 (de) Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel.
DE69332707D1 (de) Verfahren zur Herstellung von 3-Vinylcephalosporinen
ATE92074T1 (de) Beta-d-phenylthioxyloside, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE35681T1 (de) 4,4-dimethyl-tetrahydro-2h-pyran-2-on-derivate, verfahren zu deren herstellung und deren verwendung fuer die synthese von cyclopropanischen derivaten.
ATE150780T1 (de) Verwendung von phosphanen und/oder diphosphanen bei der herstellung von kunststoffen auf isocyanatbasis
ATE36321T1 (de) (bis(substituiertes methyl)methyl>isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
DE3669508D1 (de) Verbrueckungsreagenz, verfahren zu seiner herstellung und seine anwendung.
ATE35545T1 (de) Stickstoff enthaltende benzotricyclische dione und verfahren zu ihrer herstellung.
ATE66463T1 (de) 1,4-cyclohexandiamine, verfahren zu ihrer herstellung und ihre verwendung als fungizide.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties